Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Company profile
Ticker
BCPC
Exchange
Website
CEO
Theodore Harris
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Huntsman • Chemours • FMC • Ecovyst • Olin • Perimeter Solutions • GCP Applied • Ingevity • Innospec • Livent ...
SEC CIK
Corporate docs
Subsidiaries
Aberco, Inc. • Albion Laboratories, Inc. • Balchem BV • Balchem Italia Srl • Balchem Ltd. • Balchem NV • Balchem Pty Ltd. • Balchem Sdn Bhd • BCP Ingredients, Inc. • Biogenic Innovations, LLC ...
IRS number
132578432
BCPC stock data
Analyst ratings and price targets
Latest filings (excl ownership)
10-K
2022 FY
Annual report
24 Feb 23
8-K
Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results
24 Feb 23
8-K
Amendments to Articles of Incorporation or Bylaws
7 Dec 22
8-K
Balchem Corporation Announces Dividend
6 Dec 22
10-Q
2022 Q3
Quarterly report
4 Nov 22
8-K
Balchem Corporation Reports Third Quarter Sales of $244.3 Million, Net Earnings of $25.2 Million, GAAP EPS of $0.78, and Adjusted EPS of $1.00
4 Nov 22
8-K
Departure of Directors or Certain Officers
29 Sep 22
8-K
Departure of Directors or Certain Officers
20 Sep 22
8-K/A
Financial Statements and Exhibits
6 Sep 22
8-K
Balchem Corporation acquires Bergstrom Nutrition
30 Aug 22
Transcripts
BCPC
Earnings call transcript
2022 Q4
24 Feb 23
BCPC
Earnings call transcript
2022 Q3
4 Nov 22
BCPC
Earnings call transcript
2022 Q2
29 Jul 22
BCPC
Earnings call transcript
2022 Q1
29 Apr 22
BCPC
Earnings call transcript
2021 Q4
18 Feb 22
BCPC
Earnings call transcript
2021 Q3
29 Oct 21
BCPC
Earnings call transcript
2021 Q2
1 Aug 21
BCPC
Earnings call transcript
2021 Q1
2 May 21
BCPC
Earnings call transcript
2020 Q4
19 Feb 21
BCPC
Earnings call transcript
2020 Q3
28 Oct 20
Latest ownership filings
4
David B Fischer
22 Mar 23
4
Gunsteren Job Leonard van
15 Feb 23
4
Michael Brent Tignor
15 Feb 23
4
Carl Martin Bengtsson
15 Feb 23
4
JOHN Y TELEVANTOS
15 Feb 23
4
Michael Robert Sestrick
15 Feb 23
4
Theodore L Harris
15 Feb 23
4
William A. Backus
15 Feb 23
4
Jonathan Harrison Griffin
15 Feb 23
4
Michael Brent Tignor
10 Feb 23
Financial summary
Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 66.56 mm | 66.56 mm | 66.56 mm | 66.56 mm | 66.56 mm | 66.56 mm |
Cash burn (monthly) | (no burn) | 3.06 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 8.94 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 57.62 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 18.8 | n/a | n/a | n/a | n/a |
Institutional ownership, Q4 2022
13F holders | Current |
---|---|
Total holders | 289 |
Opened positions | 39 |
Closed positions | 24 |
Increased positions | 103 |
Reduced positions | 94 |
13F shares | Current |
---|---|
Total value | 3.44 tn |
Total shares | 31.52 mm |
Total puts | 4.10 k |
Total calls | 4.90 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 4.97 mm | $607.21 bn |
Vanguard | 3.84 mm | $469.08 bn |
APG Asset Management US | 2.72 mm | $0.00 |
APG Asset Management | 2.70 mm | $332.53 bn |
Wasatch Advisors | 1.63 mm | $199.00 bn |
STT State Street | 1.06 mm | $130.67 bn |
Conestoga Capital Advisors | 1.04 mm | $127.06 bn |
Geneva Capital Management | 750.32 k | $91.62 bn |
Schroder Investment Management | 697.20 k | $85.13 bn |
Dimensional Fund Advisors | 655.32 k | $80.62 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Mar 23 | Fischer David B | Common Stock | Sell | Dispose S | No | No | 127.007 | 3,000 | 381.02 k | 17,269 |
13 Feb 23 | Michael Bent Tignor | Common Stock | Payment of exercise | Dispose F | No | No | 135.67 | 297 | 40.29 k | 7,879 |
13 Feb 23 | John Y Televantos | Common Stock | Payment of exercise | Dispose F | No | No | 135.67 | 258 | 35.00 k | 29,078 |
13 Feb 23 | Michael Robert Sestrick | Common Stock | Payment of exercise | Dispose F | No | No | 135.67 | 278 | 37.72 k | 7,618 |
13 Feb 23 | Theodore L Harris | Common Stock | Payment of exercise | Dispose F | No | No | 135.67 | 2,568 | 348.40 k | 83,897 |
Press releases
Balchem Corporation Reports Fourth Quarter Net Sales Growth of 9.1% and Strong Full Year 2022 Results
24 Feb 23
Balchem Corporation Announces Quarterly Conference Call for Fourth Quarter Financial Results on February 24, 2023
10 Feb 23
Balchem Corporation Named on Newsweek's 2023 List of America's Most Responsible Companies
6 Jan 23
Balchem Corporation to Present at the CJS Securities 23rd Annual "New Ideas for the New Year" Investor Conference January 11, 2023
3 Jan 23